Protease inhibitors: First generation, second generation and combinations

被引：0
|
作者：
Mellors, JW
机构：
[1] Univ Pittsburgh, HIV AIDS Program, Pittsburgh, PA 15260 USA
[2] Pittsburgh Vet Affairs Med Ctr, Pittsburgh, PA USA
来源：
AIDS | 1998年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
PL71
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [21] First-generation vs second-generation antihistamines
    Aelony, Y
    ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (17) : 1949 - 1949
  • [22] Mood Stabilizers of First and Second Generation
    Rybakowski, Janusz K.
    BRAIN SCIENCES, 2023, 13 (05)
  • [23] Total synthesis of a second generation HIV protease inhibitor
    Gauthier, DR
    Ikemoto, N
    Fleitz, FJ
    Szumigala, RH
    Petrillo, D
    Liu, JC
    Reamer, RA
    Armstrong, JD
    Yehl, PM
    Wu, NJ
    Volante, RP
    TETRAHEDRON-ASYMMETRY, 2003, 14 (22) : 3557 - 3567
  • [24] First and second generation AUSSAT systems
    Hope, W.
    JBIS. Journal of the British Interplanetary Society, 1988, 41 (12): : 587 - 598
  • [25] The Formation of the First Second Generation Star
    Smith, Britton D.
    Wise, John H.
    O'Shea, Brian W.
    FIRST STARS IV - FROM HAYASHI TO THE FUTURE, 2012, 1480 : 135 - 138
  • [26] First generation inhibitors of the adenovirus proteinase
    McGrath, William J.
    Graziano, Vito
    Zabrocka, Katarzyna
    Mangel, Walter F.
    FEBS LETTERS, 2013, 587 (15) : 2332 - 2339
  • [27] COMPARATIVE EFFECTIVENESS OF ANTIVIRAL THERAPY FOR PRIOR NULL RESPONDERS IN THE ERA OF FIRST GENERATION PROTEASE INHIBITORS
    Kim, W. Ray
    Gross, John B.
    Poterucha, John J.
    HEPATOLOGY, 2011, 54 : 797A - 797A
  • [28] Patients Treated With First-Generation HCV Protease Inhibitors Exhibit High Ribavirin Concentrations
    Bodeau, Sandra
    Nguyen-Khac, Eric
    Solas, Caroline
    Bennis, Youssef
    Capron, Dominique
    Duverlie, Gilles
    Brochot, Etienne
    JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (05): : 517 - 524
  • [29] Triple therapy with first generation HCV protease inhibitors: Lead-in or no lead-in phase?
    Pascale, Alina
    Serfaty, Lawrence
    JOURNAL OF HEPATOLOGY, 2013, 58 (02) : 391 - 394
  • [30] Ethical assessment of hepatitis C virus treatment: The lesson from first generation protease inhibitors
    Sacchini, Dario
    Craxi, Lucia
    Refolo, Pietro
    Minacori, Roberta
    Cicchetti, Americo
    Gasbarrini, Antonio
    Camma, Calogero
    Spagnolo, Antonio G.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (05) : 351 - 355
12345